0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Primary Cell Culture Market Size, Share & Trends Analysis Report by Product (Primary Cells, Media), Cell Type (Human Cells, Animal Cells) by Application (Cell & Gene Therapy Development), End-Use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 4668021
The Primary Cell Culture Market was valued at USD 4.79 billion in 2024, and is projected to reach USD 8.67 billion by 2030, rising at a CAGR of 10.55%. The market is projected to grow at a CAGR of 10.55% from 2025 to 2030. The increasing demand for personalized and precision therapies has fueled the need for more accurate and relevant in vitro models. Primary cell culture provides a closer representation of human biology and physiology compared to traditional cell lines, making it an indispensable tool for studying disease mechanisms, drug discovery, and therapeutic development. Researchers and pharmaceutical companies are increasingly recognizing the importance of primary cell culture for improving the success rates of drug candidates, reducing costly late-stage failures, and ultimately delivering more effective and targeted treatments to patients.

Moreover, the field of regenerative medicine aims to replace or repair damaged tissues and organs, and primary cell culture plays a vital role in developing and engineering functional tissues. Primary cells are used to create tissue constructs, organoids, and bioengineered implants that closely mimic the structure and function of native tissues. These advancements have significant implications for regenerative medicine therapies, including tissue transplantation, wound healing, and the treatment of degenerative diseases. For instance, in April 2023, Mount Sinai launched a new institute for regenerative medicine to foster novel discoveries and explore new therapies for life-threatening diseases. The growing interest in regenerative medicine and the potential to revolutionize healthcare have led to increased investment and research in primary cell culture, propelling the market’s growth.

The COVID-19 pandemic has significantly impacted the primary cell culture industry. While the pandemic disrupted various industries, including healthcare and research, it highlighted the crucial role of primary cell culture in understanding viruses and developing treatments. Primary cells have been instrumental in studying the mechanisms of SARS-CoV-2 infection, testing antiviral therapies, and evaluating vaccine efficacy. The pandemic has accelerated the demand for primary cell culture products and services as researchers worldwide focused on COVID-19-related studies.

Furthermore, several developments undertaken by key market participants, and increasing industry-academia collaborations are driving the global market. For instance, in January 2023, Bio-Trac and ATCC collaborated to conduct a training workshop to offer an overview of the principles of primary cell culture, organoids and spheroids, and other related cell culture techniques.

Primary Cell Culture Market Report Highlights

  • By product, the reagent and supplements segment dominated with a share of 37.7% in 2024, due availability of a wide range of high-quality reagents and supplements tailored for specific cell types and research applications
  • By separation method, the enzymatic degradation segment dominated the market with a share of 32.15% in 2024, due to the advantages of this method such as less damage to cultures, a relatively short turnaround time, and a high output of sample representation
  • By cell type, the animal cells segment is expected to grow lucratively over the forecast period. The high growth of the segment is attributed to the versatility, wide availability, and established research protocols for this cell type
  • North America established a strong regional position in the global market with a 41.58% share in 2024 due to its highly developed healthcare infrastructure and favorable government policies

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Cell Type Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising usage of primary cell culture products in in-vitro testing and drug screening
3.2.1.2. Increasing in demand for stem cell therapy and regenerative medicine
3.2.1.3. Rising incidence of cancer and other chronic diseases
3.2.1.4. Advancement in genetic engineering protocols
3.2.1.5. Rise in research funding for functional biology and research
3.2.2. Market Restraint Analysis
3.2.2.1. Ethical and regulatory concerns related with the use of primary cells
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Primary Cell Culture Market: Product Business Analysis
4.1. Product Segment Dashboard
4.2. Global Primary Cell Culture Market Product Movement Analysis
4.3. Global Primary Cell Culture Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Primary Cells
4.4.1. Global Primary Cells Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Hematopoietic Cells
4.4.2.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Skin Cells
4.4.3.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Hepatocytes
4.4.4.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Gastrointestinal Cells
4.4.5.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Lung Cells
4.4.6.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Renal Cells
4.4.7.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Heart Cells
4.4.8.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.9. Skeletal and Muscle Cells
4.4.9.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
4.4.10. Other Primary Cells
4.4.10.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Media
4.5.1. Global Media Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Serum-free Media
4.5.2.1. Global Serum-free Media Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Serum-containing Media
4.5.3.1. Global Serum-containing Media Market and Forecasts, 2018-2030 (USD Million)
4.5.4. Other Media
4.5.4.1. Global Other Media Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Reagents and Supplements
4.6.1. Global Reagents and Supplements Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.2. Attachment Solutions
4.6.2.1. Global Attachment Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.3. Buffers and Salts
4.6.3.1. Global Buffers and Salts Market and Forecasts, 2018-2030 (USD Million)
4.6.4. Sera
4.6.4.1. Global Sera Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.5. Growth Factors and Cytokines
4.6.5.1. Global Growth Factors and Cytokines Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.6. Freezing Media
4.6.6.1. Global Freezing Media Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.7. Others
4.6.7.1. Global Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Primary Cell Culture Market: Application Business Analysis
5.1. Application Segment Dashboard
5.2. Global Primary Cell Culture Market Application, Movement Analysis
5.3. Global Primary Cell Culture Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Vaccine Production
5.4.1. Global Vaccine Production Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Cell & Gene Therapy Development
5.5.1. Global Cell & Gene Therapy Development Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Model System
5.6.1. Global Model System Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Virology
5.7.1. Global Virology Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Prenatal Diagnosis
5.8.1. Global Prenatal Diagnosis Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9. Other Applications
5.9.1. Global Other Applications Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Primary Cell Culture Market: Cell Type Business Analysis
6.1. Cell Type Segment Dashboard
6.2. Global Primary Cell Culture Market Cell Type Movement Analysis
6.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Human Cells
6.4.1. Global Human Cells Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Animal Cells
6.5.1. Global Animal Cells Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Primary Cell Culture Market: End Use Business Analysis
7.1. End Use Segment Dashboard
7.2. Global Primary Cell Culture Market End Use Movement Analysis
7.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. CMOs & CROs
7.5.1. Global CMOs & CROs Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Academic Research Institutes
7.6.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Primary Cell Culture Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. North America
8.3.1. North America Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Mexico Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Europe
8.4.1. Europe Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. France Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Italy Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Spain Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.5. Australia
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Australia Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. South Korea Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Latin America
8.6.1. Latin America Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Argentina
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Argentina Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7. MEA
8.7.1. MEA Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.4. UAE
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. UAE Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait Primary Cell Culture Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Participant’s Overview
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. STEMCELL Technologies
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Merck KGaA
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Lonza
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Cell Biologics, Inc.
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. PromoCell GMBH
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. ZenBio
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. AllCells
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. American Type Culture Collection
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Axol Biosciences Ltd.
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Primary Cell Culture market, by product, 2018-2030 (USD Million)
Table 3 Primary Cell Culture market, by end use, 2018-2030 (USD Million)
Table 4 Primary Cell Culture market, by cell type, 2018-2030 (USD Million)
Table 5 Primary Cell Culture market, by application, 2018-2030 (USD Million)
Table 6 Primary Cell Culture market, by region, 2018-2030 (USD Million)
Table 7 North America primary cell culture market, by country, 2018-2030 (USD Million)
Table 8 North America primary cell culture market, by product, 2018-2030 (USD Million)
Table 9 North America primary cell culture market, by end use, 2018-2030 (USD Million)
Table 10 North America primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 11 North America primary culture market, by application, 2018-2030 (USD Million)
Table 12 U.S. primary cell culture market, by product, 2018-2030 (USD Million)
Table 13 U.S. primary cell culture market, by end use, 2018-2030 (USD Million)
Table 14 U.S. primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 15 U.S. primary cell culture market, by application, 2018-2030 (USD Million)
Table 16 Canada primary cell culture market, by product, 2018-2030 (USD Million)
Table 17 Canada primary cell culture market, by end use, 2018-2030 (USD Million)
Table 18 Canada primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 19 Canada primary cell culture market, by application, 2018-2030 (USD Million)
Table 20 Mexico primary cell culture market, by product, 2018-2030 (USD Million)
Table 21 Mexico primary cell culture market, by end use, 2018-2030 (USD Million)
Table 22 Mexico primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 23 Mexico primary cell culture market, by application, 2018-2030 (USD Million)
Table 24 Europe primary cell culture market, by country, 2018-2030 (USD Million)
Table 25 Europe primary cell culture market, by product, 2018-2030 (USD Million)
Table 26 Europe primary cell culture market, by end use, 2018-2030 (USD Million)
Table 27 Europe primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 28 Europe primary cell culture market, by application, 2018-2030 (USD Million)
Table 29 UK primary cell culture market, by product, 2018-2030 (USD Million)
Table 30 UK primary cell culture market, by end use, 2018-2030 (USD Million)
Table 31 UK primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 32 UK primary cell culture market, by application, 2018-2030 (USD Million)
Table 33 Germany primary cell culture market, by product, 2018-2030 (USD Million)
Table 34 Germany primary cell culture market, by end use, 2018-2030 (USD Million)
Table 35 Germany primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 36 Germany primary cell culture market, by application, 2018-2030 (USD Million)
Table 37 France primary cell culture market, by product, 2018-2030 (USD Million)
Table 38 France primary cell culture market, by end use, 2018-2030 (USD Million)
Table 39 France primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 40 France primary cell culture market, by application, 2018-2030 (USD Million)
Table 41 Italy primary cell culture market, by product, 2018-2030 (USD Million)
Table 42 Italy primary cell culture market, by end use, 2018-2030 (USD Million)
Table 43 Italy primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 44 Italy primary cell culture market, by application, 2018-2030 (USD Million)
Table 45 Spain primary cell culture market, by product, 2018-2030 (USD Million)
Table 46 Spain primary cell culture market, by end use, 2018-2030 (USD Million)
Table 47 Spain primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 48 Spain primary cell culture market, by application, 2018-2030 (USD Million)
Table 49 Denmark primary cell culture market, by product, 2018-2030 (USD Million)
Table 50 Denmark primary cell culture market, by end use, 2018-2030 (USD Million)
Table 51 Denmark primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 52 Denmark primary cell culture market, by application, 2018-2030 (USD Million)
Table 53 Sweden primary cell culture market, by product, 2018-2030 (USD Million)
Table 54 Sweden primary cell culture market, by end use, 2018-2030 (USD Million)
Table 55 Sweden primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 56 Sweden primary cell culture market, by application, 2018-2030 (USD Million)
Table 57 Norway primary cell culture market, by product, 2018-2030 (USD Million)
Table 58 Norway primary cell culture market, by end use, 2018-2030 (USD Million)
Table 59 Norway primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 60 Norway primary cell culture market, by application, 2018-2030 (USD Million)
Table 61 Asia Pacific primary cell culture market, by country, 2018-2030 (USD Million)
Table 62 Asia Pacific primary cell culture market, by product, 2018-2030 (USD Million)
Table 63 Asia Pacific primary cell culture market, by end use, 2018-2030 (USD Million)
Table 64 Asia Pacific primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 65 Asia Pacific primary cell culture market, by application, 2018-2030 (USD Million)
Table 66 Japan primary cell culture market, by product, 2018-2030 (USD Million)
Table 67 Japan primary cell culture market, by end use, 2018-2030 (USD Million)
Table 68 Japan primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 69 Japan primary cell culture market, by application, 2018-2030 (USD Million)
Table 70 China primary cell culture market, by product, 2018-2030 (USD Million)
Table 71 China primary cell culture market, by end use, 2018-2030 (USD Million)
Table 72 China primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 73 China primary cell culture market, by application, 2018-2030 (USD Million)
Table 74 India primary cell culture market, by product, 2018-2030 (USD Million)
Table 75 India primary cell culture market, by end use, 2018-2030 (USD Million)
Table 76 India primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 77 India primary cell culture market, by application, 2018-2030 (USD Million)
Table 78 Australia primary cell culture market, by product, 2018-2030 (USD Million)
Table 79 Australia primary cell culture market, by end use, 2018-2030 (USD Million)
Table 80 Australia primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 81 Australia primary cell culture market, by application, 2018-2030 (USD Million)
Table 82 Thailand primary cell culture market, by product, 2018-2030 (USD Million)
Table 83 Thailand primary cell culture market, by end use, 2018-2030 (USD Million)
Table 84 Thailand primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 85 Thailand primary cell culture market, by application, 2018-2030 (USD Million)
Table 86 South Korea primary cell culture market, by product, 2018-2030 (USD Million)
Table 87 South Korea primary cell culture market, by end use, 2018-2030 (USD Million)
Table 88 South Korea primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 89 South Korea primary cell culture market, by application, 2018-2030 (USD Million)
Table 90 Latin America primary cell culture market, by country, 2018-2030 (USD Million)
Table 91 Latin America primary cell culture market, by product, 2018-2030 (USD Million)
Table 92 Latin America primary cell culture market, by end use, 2018-2030 (USD Million)
Table 93 Latin America primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 94 Latin America primary cell culture market, by application, 2018-2030 (USD Million)
Table 95 Brazil primary cell culture market, by product, 2018-2030 (USD Million)
Table 96 Brazil primary cell culture market, by end use, 2018-2030 (USD Million)
Table 97 Brazil primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 98 Brazil primary cell culture market, by application, 2018-2030 (USD Million)
Table 99 Argentina primary cell culture market, by product, 2018-2030 (USD Million)
Table 100 Argentina primary cell culture market, by end use, 2018-2030 (USD Million)
Table 101 Argentina primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 102 Argentina primary cell culture market, by application, 2018-2030 (USD Million)
Table 103 Middle East & Africa primary cell culture market, by country, 2018-2030 (USD Million)
Table 104 Middle East & Africa primary cell culture market, by product, 2018-2030 (USD Million)
Table 105 Middle East & Africa primary cell culture market, by end use, 2018-2030 (USD Million)
Table 106 Middle East & Africa primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 107 Middle East & Africa primary cell culture market, by application, 2018-2030 (USD Million)
Table 108 South Africa primary cell culture market, by product, 2018-2030 (USD Million)
Table 109 South Africa primary cell culture market, by end use, 2018-2030 (USD Million)
Table 110 South Africa primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 111 South Africa primary cell culture market, by application, 2018-2030 (USD Million)
Table 112 Saudi Arabia primary cell culture market, by product, 2018-2030 (USD Million)
Table 113 Saudi Arabia primary cell culture market, by end use, 2018-2030 (USD Million)
Table 114 Saudi Arabia primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 115 Saudi Arabia primary cell culture market, by application, 2018-2030 (USD Million)
Table 116 UAE primary cell culture market, by product, 2018-2030 (USD Million)
Table 117 UAE primary cell culture market, by end use, 2018-2030 (USD Million)
Table 118 UAE primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 119 UAE primary cell culture market, by application, 2018-2030 (USD Million)
Table 120 Kuwait primary cell culture market, by product, 2018-2030 (USD Million)
Table 121 Kuwait primary cell culture market, by end use, 2018-2030 (USD Million)
Table 122 Kuwait primary cell culture market, by cell type, 2018-2030 (USD Million)
Table 123 Kuwait primary cell culture market, by application, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Primary Cell Culture market segmentation
Figure 7 Market snapshot, 2024
Figure 8 Market trends & outlook
Figure 9 Market driver relevance analysis
Figure 10 Market restraint relevance analysis
Figure 11 PESTEL analysis
Figure 12 Porter’s five forces analysis
Figure 13 Primary Cell Culture market: Product movement analysis
Figure 14 Primary Cell Culture market, for primary cells, 2018-2030 (USD Million)
Figure 15 Primary Cell Culture market, for reagents and supplements, 2018-2030 (USD Million)
Figure 16 Primary Cell Culture market, for media, 2018-2030 (USD Million)
Figure 17 Primary Cell Culture market: end use movement analysis
Figure 18 Primary Cell Culture market, for pharmaceutical and biotechnology companies
Figure 19 Primary Cell Culture market, for CMOs & CROs
Figure 20 Primary Cell Culture market, for Academic Research Institutes
Figure 21 Primary Cell Culture market: Cell Type movement analysis
Figure 22 Primary Cell Culture market, for animal cells, 2018-2030 (USD Million)
Figure 23 Primary Cell Culture market, for human cells, 2018-2030 (USD Million)
Figure 24 Primary Cell Culture market: Application movement analysis
Figure 25 Primary Cell Culture market, for cell & gene therapy development, 2018-2030 (USD Million)
Figure 26 Primary Cell Culture market, for vaccine production, 2018-2030 (USD Million)
Figure 27 Primary Cell Culture market, for model system, 2018-2030 (USD Million)
Figure 28 Primary Cell Culture market, for virology, 2018-2030 (USD Million)
Figure 29 Primary Cell Culture market, for prenatal diagnosis, 2018-2030 (USD Million)
Figure 30 Primary Cell Culture market, for others applications, 2018-2030 (USD Million)
Figure 31 Regional marketplace: Key takeaways
Figure 32 Regional outlook, 2024 & 2030
Figure 33 Primary Cell Culture market: Region movement analysis
Figure 34 North America Primary Cell Culture market, 2018-2030 (USD Million)
Figure 35 U.S. Primary Cell Culture market, 2018-2030 (USD Million)
Figure 36 Canada Primary Cell Culture market, 2018-2030 (USD Million)
Figure 37 Mexico Primary Cell Culture market, 2018-2030 (USD Million)
Figure 38 Europe Primary Cell Culture market, 2018-2030 (USD Million)
Figure 39 Germany Primary Cell Culture market, 2018-2030 (USD Million)
Figure 40 UK Primary Cell Culture market, 2018-2030 (USD Million)
Figure 41 France Primary Cell Culture market, 2018-2030 (USD Million)
Figure 42 Italy Primary Cell Culture market, 2018-2030 (USD Million)
Figure 43 Spain Primary Cell Culture market, 2018-2030 (USD Million)
Figure 44 Denmark Primary Cell Culture market, 2018-2030 (USD Million)
Figure 45 Sweden Primary Cell Culture market, 2018-2030 (USD Million)
Figure 46 Norway Primary Cell Culture market, 2018-2030 (USD Million)
Figure 47 Asia Pacific Primary Cell Culture market, 2018-2030 (USD Million)
Figure 48 Japan Primary Cell Culture market, 2018-2030 (USD Million)
Figure 49 China Primary Cell Culture market, 2018-2030 (USD Million)
Figure 50 India Primary Cell Culture market, 2018-2030 (USD Million)
Figure 51 Australia Primary Cell Culture market, 2018-2030 (USD Million)
Figure 52 South Korea Primary Cell Culture market, 2018-2030 (USD Million)
Figure 53 Thailand Primary Cell Culture market, 2018-2030 (USD Million)
Figure 54 Latin America Primary Cell Culture market, 2018-2030 (USD Million)
Figure 55 Brazil Primary Cell Culture market, 2018-2030 (USD Million)
Figure 56 Argentina Primary Cell Culture market, 2018-2030 (USD Million)
Figure 57 Middle East and Africa Primary Cell Culture market, 2018-2030 (USD Million)
Figure 58 South Africa Primary Cell Culture market, 2018-2030 (USD Million)
Figure 59 Saudi Arabia Primary Cell Culture market, 2018-2030 (USD Million)
Figure 60 UAE Primary Cell Culture market, 2018-2030 (USD Million)
Figure 61 Kuwait Primary Cell Culture market, 2018-2030 (USD Million)

Companies Mentioned

The major companies profiled in this Primary Cell Culture market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza
  • STEMCELL Technologies
  • Cell Biologics, Inc.
  • PromoCell
  • ZenBio
  • AllCells
  • American Type Culture Collection
  • Axol Biosciences Ltd.

Methodology

Table Information

This website uses cookies to ensure you get the best experience. Learn more